Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.57 |
| ▸ | GSR | P00390 | 1/20 | 0.48 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.48 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.47 |
| ▸ | TLR2 | O60603 | 1/20 | 0.44 |
| ▸ | GGT1 | P19440 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | CPB2 | Q96IY4 | 11/20 | 0.43 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2151316 | 1.00 | FOLH1 (0.57) | FOLH1GSRSLC6A5RNPEPTLR2 | |
| Water SCHEMBL28303756 | 0.98 | FOLH1 (0.56) | FOLH1GSRSLC6A5RNPEPTLR2 | |
| Hydrochloric Acid SCHEMBL3647090 | 0.98 | FOLH1 (0.56) | FOLH1GSRSLC6A5RNPEPTLR2 | |
| Hydrochloric Acid SCHEMBL29268898 | 0.98 | FOLH1 (0.56) | FOLH1GSRSLC6A5RNPEPTLR2 | |
| Ammonia Solution, Strong SCHEMBL4951257 | 0.98 | FOLH1 (0.56) | FOLH1GSRSLC6A5RNPEPTLR2 | |
| Hydrochloric Acid SCHEMBL28514579 | 0.98 | FOLH1 (0.56) | FOLH1GSRSLC6A5RNPEPTLR2 | |
| SCHEMBL20448161 | 0.94 | FOLH1 (0.50) | FOLH1GSRSLC6A5RNPEPTLR2 | |
| SCHEMBL31739266 | 0.94 | FOLH1 (0.50) | FOLH1GSRSLC6A5RNPEPTLR2 | |
| Ammonia Solution, Strong SCHEMBL4951217 | 0.92 | FOLH1 (0.49) | FOLH1GSRSLC6A5RNPEPTLR2 | |
| Hydrochloric Acid SCHEMBL20482193 | 0.92 | FOLH1 (0.49) | FOLH1GSRSLC6A5RNPEPTLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119925300-A | IL 12 mRNA lipid nanoparticle and preparation method and application thereof | 杭州宜生医药科技发展有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119770369-A | Lipopeptide-small molecule polypeptide supermolecule composition and preparation method and application thereof | 江南大学 | 2025-04-08 | — | — | CN | claimed |
| EP-4522221-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACID THERAPEUTICS | Entrada Therapeutics, Inc. (US) | 2025-03-19 | — | — | EP | claimed |
| EP-4359006-A1 | ANTISENSE COMPOUNDS AND METHODS FOR TARGETING CUG REPEATS | Entrada Therapeutics, Inc. (US) | 2024-05-01 | — | — | EP | claimed |
| CN-117957022-A | Antisense compounds and methods for targeting CUG repeats | 安卓达治疗股份有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-117915957-A | Compositions and methods for modulating mRNA splicing | 恩特拉达治疗学股份有限公司 | 2024-04-19 | — | — | CN | claimed |
| EP-4337261-A2 | COMPOSITIONS AND METHODS FOR MODULATING MRNA SPLICING | Entrada Therapeutics, Inc. (US) | 2024-03-20 | — | — | EP | claimed |
| EP-4337263-A1 | COMPOSITIONS AND METHODS FOR MODULATING INTERFERON REGULATORY FACTOR-5 (IRF-5) ACTIVITY | Entrada Therapeutics, Inc. (US) | 2024-03-20 | — | — | EP | claimed |
| EP-4337676-A1 | ANTIGEN-BINDING AND ANTIGEN DEGRADATION CONSTRUCTS | Entrada Therapeutics, Inc. (US) | 2024-03-20 | — | — | EP | claimed |
| CN-117561271-A | Cyclic cell penetrating peptides | 恩特拉达治疗公司 | 2024-02-13 | — | — | CN | claimed |
| WO-2018227106-A2 | METHODS FOR IMPROVING CARDIOVASCULAR DISEASE MANAGEMENT | PREVENTAGE HEALTHCARE LLC (US) | 2018-12-13 | — | — | WO | claimed |
| US-20180306747-A1 | METHODS FOR IMPROVING DIABETES MANAGEMENT | PREVENAGE HEALTHCARE LLC (US) | 2018-10-25 | — | — | US | claimed |
| EP-2706360-B1 | Method and kit for improving diabetes management by determining methylglyoxal hydroimidazolone (MGH1) | PREVENTAGE HEALTHCARE LLC (US) | 2018-10-03 | — | — | EP | claimed |
| US-10018591-B2 | Methods for improving diabetes management | PREVENTAGE HEALTHCARE, LLC (US) | 2018-07-10 | — | — | US | claimed |
| CN-106727672-A | It is a kind of to treat medicine of vascular headache and preparation method thereof | 河南八灵电子科技有限公司 | 2017-05-31 | — | — | CN | claimed |
| EP-2706360-A1 | Methods for improving diabetes management | PreventAge Healthcare, LLC (US) | 2014-03-12 | — | — | EP | claimed |
| US-20130345175-A1 | Methods for Improving Diabetes Management | PREVENTAGE HEALTHCARE, LLC | 2013-12-26 | — | — | US | claimed |
| US-6811965-B2 | REPERFUSION SOLUTION FOR USE IN THE PRESERVATION OF ORGAN TISSUE | HERMACELL PERFUSION, INC. | 2004-11-02 | — | — | US | claimed |
| US-20030104348-A1 | Kidney perfusion solution containing nitric oxide donor | HERMACELL PERFUSION, INC. | 2003-06-05 | — | — | US | claimed |
| WO-2001065935-A1 | KIDNEY PERFUSION SOLUTION CONTAINING NITRIC OXIDE DONOR | VODOVOTZ YORAM (US) | 2001-09-13 | — | — | WO | claimed |